These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 15585453)
1. Economics of antibiotic use policies. Paladino JA Pharmacotherapy; 2004 Dec; 24(12 Pt 2):232S-8S. PubMed ID: 15585453 [TBL] [Abstract][Full Text] [Related]
2. [Antibiotic pharmacoeconomics]. Jahnz-Rózyk K Pol Merkur Lekarski; 2008 Nov; 25(149):437-8. PubMed ID: 19177784 [TBL] [Abstract][Full Text] [Related]
3. [Clinical effectiveness and costs of antibiotics in respiratory infections]. Jahnz-Rózyk K Pol Merkur Lekarski; 2011 May; 30(179):327-9. PubMed ID: 21675134 [TBL] [Abstract][Full Text] [Related]
4. Clinical and economic impact of an antibiotics stewardship programme in a regional hospital in Hong Kong. Ng CK; Wu TC; Chan WM; Leung YS; Li CK; Tsang DN; Leung GM Qual Saf Health Care; 2008 Oct; 17(5):387-92. PubMed ID: 18842981 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic cost control measures in a hospital pharmacy. Manzo J; Amodio-Groton MA; Kleinmann K Clin Ther; 1993; 15 Suppl A():37-43. PubMed ID: 8513460 [TBL] [Abstract][Full Text] [Related]
6. Economics of antibiotic resistance. Sipahi OR Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118 [TBL] [Abstract][Full Text] [Related]
7. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. MacKenzie FM; Gould IM; Bruce J; Mollison J; Monnet DL; Krcmery V; Cookson B; van der Meer JW J Hosp Infect; 2007 Jun; 65 Suppl 2():73-81. PubMed ID: 17540246 [TBL] [Abstract][Full Text] [Related]
8. [Health economics and antibiotic therapy]. Leclercq P; Bigdéli M Rev Med Brux; 1995; 16(4):320-4. PubMed ID: 7481251 [TBL] [Abstract][Full Text] [Related]
9. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Paterson DL Clin Infect Dis; 2006 Jan; 42 Suppl 2():S90-5. PubMed ID: 16355322 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacoeconomics of infection in the intensive care unit]. Grau S; Alvarez-Lerma F Rev Esp Quimioter; 2008; 21 Spec No 1():26-34. PubMed ID: 18752077 [TBL] [Abstract][Full Text] [Related]
11. Economic aspects of antimicrobial therapy of acute exacerbations of COPD. Simoens S; Decramer M; Laekeman G Respir Med; 2007 Jan; 101(1):15-26. PubMed ID: 16650975 [TBL] [Abstract][Full Text] [Related]
12. The value of infectious diseases specialists: non-patient care activities. McQuillen DP; Petrak RM; Wasserman RB; Nahass RG; Scull JA; Martinelli LP Clin Infect Dis; 2008 Oct; 47(8):1051-63. PubMed ID: 18781883 [TBL] [Abstract][Full Text] [Related]
15. Methods of controlling cephalosporin use in Canadian hospitals. Godin JP; Sketris IS; Merrett RA; Marrie TJ Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052 [TBL] [Abstract][Full Text] [Related]
16. A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century. Paskovaty A; Pflomm JM; Myke N; Seo SK Int J Antimicrob Agents; 2005 Jan; 25(1):1-10. PubMed ID: 15620820 [TBL] [Abstract][Full Text] [Related]
17. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I. Kusowska J Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989 [TBL] [Abstract][Full Text] [Related]
18. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II. Kusowska J Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990 [TBL] [Abstract][Full Text] [Related]
19. The pharmacoeconomics of acne treatment: where are we heading? Inglese MJ; Fleischer AB; Feldman SR; Balkrishnan R J Dermatolog Treat; 2008; 19(1):27-37. PubMed ID: 18273722 [TBL] [Abstract][Full Text] [Related]
20. Antibiotic therapy 1985: what are the challenges? Cohen MS Hosp Formul; 1985 Dec; 20(12):1247-8. PubMed ID: 10311346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]